Sign in

Trial result ·

Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG-2015 French Innovative Leukemia Organization phase 2 randomized trial.

Written based on 1 research study on PubMed, searched on 3 Nov 2026.

What was studied

This phase 2 trial tested eltrombopag in older people with new acute myeloid leukemia. They were getting intensive chemotherapy. The trial ran at 18 hospitals in France, from October 2018 to June 2021. In all, 110 people aged 60 or more were randomly assigned, 55 per group. It was blinded, and the comparison was placebo. The drug started on Day 11 after induction chemotherapy.

What they found

After induction, 90 people had a complete response, some with incomplete blood recovery. That was 45 in each group. Median follow-up for living patients was 20.9 months. The main goal was not reached, as overall survival did not differ. Eltrombopag did not raise grade 3/4 side effects. People on it needed fewer platelet transfusions.

What it means for patients

The authors say the trial did not show a survival gain, unlike earlier reports. They say it is feasible and safe to start eltrombopag once chemotherapy has cleared. They say it lowered the need for platelet transfusions.

Why it is not certain yet

The main goal was not reached. The trial had 110 people. The drug was given only until response checks or platelet recovery. The abstract does not give results beyond survival, side effects and transfusions.

Source

Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG-2015 French Innovative Leukemia Organization phase 2 randomized trial.

PubMed · PMID 42963911

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Acute myeloid leukaemia publications